Showing results (911-920 of 3,081) with videos related to

Sort By:
Pageof 309
Drug Safety|February 17, 2016
Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP)Manfred Hauben, Jeffrey K Aronson, Robin E Ferner
Drug Safety|August 29, 2015
Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-AnalysisAlice Capogrosso Sansone, Stefania Mantarro, Marco Tuccori, et al.
Drug Safety|April 20, 2016
Diagnosis and Management of Drug-Induced Liver Injury (DILI) in Patients with Pre-Existing Liver DiseaseRolf Teschke, Gaby Danan
Drug Safety|May 5, 2019
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims DataJenna M Reps, Peter R Rijnbeek, Patrick B Ryan
Drug Safety|May 24, 2019
Auto-Generated Physiological Chain Data for an Ontological Framework for Pharmacology and Mechanism of Action to Determine Suspected Drugs in Cases of DysuriaMasayo Hayakawa, Takeshi Imai, Yoshimasa Kawazoe, et al.
Drug Safety|May 29, 2019
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort StudyAlicia Gilsenan, Joan Fortuny, Miguel Cainzos-Achirica, et al.
Drug Safety|September 27, 2018
Implications of Individual QT/RR Profiles-Part 2: Zero QTc/RR Correlations Do Not Prove QTc Correction Accuracy in Studies of QTc ChangesMarek Malik, Christine Garnett, Katerina Hnatkova, et al.
Drug Safety|May 12, 2019
Fluoroquinolone Use and the Risk of Collagen-Associated Adverse Events: A Systematic Review and Meta-AnalysisXinyu Yu, Ding-Sheng Jiang, Jing Wang, et al.
Drug Safety|October 18, 2018
Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial ExperienceJohn F Marcinak, Melvin S Munsaka, Paul B Watkins, et al.
Drug Safety|April 10, 2019
Correction to: Antipsychotic Prescribing to Patients Diagnosed with Dementia Without a Diagnosis of Psychosis in the Context of National Guidance and Drug Safety Warnings: Longitudinal Study in UK General PracticeS Jill Stocks, Evangelos Kontopantelis, Roger T Webb, et al.
Pageof 309